(Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug ...
Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...
A cancer-drug combination from Merck, Pfizer and Astellas Pharma has hit a key goal in a late-stage study in patients with a hard-to-treat form of bladder cancer. The companies on Tuesday said Merck's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results